magforce usa fighting cancer with nanotherm therapy
play

MAGFORCE USA FIGHTING CANCER WITH NANOTHERM THERAPY SPARED CRN Meeting May 3, 2018 MagForce AG Company Presentation Berlin, Germany 2 AGENDA NANOTHERM THERAPY ABLATION OF PROSTATE LESIONS Company Presentation MagForce AG

0 downloads 5 Views 610 KB Size Report
  1. MAGFORCE USA FIGHTING CANCER WITH NANOTHERM THERAPY SPARED CRN Meeting May 3, 2018 MagForce AG Company Presentation Berlin, Germany

  2. 2 AGENDA • NANOTHERM THERAPY • ABLATION OF PROSTATE LESIONS Company Presentation MagForce AG Berlin, Germany O:\Word\2018\SPARED\SPARED CRN 050318

  3. 3 WHO WE ARE • Larry Kessler, Sc.D. • Professor, University of Washington, School of Public Health • David Hammond, MS • Hammond Clinical Trial Consulting, LLC • Affiliate faculty, University of Washington, School of Pharmacy Company Presentation MagForce AG Berlin, Germany O:\Word\2018\SPARED\SPARED CRN 050318

  4. 4 NANOTHERM ABLATION TUMOR ABLATION FROM THE INSIDE OUT : Therapy components NanoPlan NanoTherm NanoActivator Brain (EU approved) Pancreas (Phase II) Prostate (Phase I) 12nm Core Coating Functional surface (Aminosilane) Mode of action Step 2 Step 1 Step 3 • NanoTherm magnetic fluid injected • The simulation takes into account the • Magnetic field causes NanoTherm directly into tumor tissue tumor size, distribution of the particles to oscillate and produce heat NanoTherm particles and tumor • Nanoparticles remain in place due to • Heat destroys or makes cells location their special coating susceptible to concomitant radio- or • Simulated temperature distribution: chemotherapy 40 ° C (blue line) to 50 ° C (red line) Company Presentation MagForce AG Berlin, Germany O:\Word\2018\SPARED\SPARED CRN 050318

  5. 5 NANOTHERM THERAPY – STRATEGY DEVELOPMENT & EXECUTION Focus on application of NanoTherm therapy for the treatment of • Brain tumors (Germany & EU 27) and • Intermediate risk prostate cancer (USA) PREVIOUS EUROPEAN CLINICAL TREATMENT EXPERIENCE MagForce AG has CE Indication Patients mark in Germany and Glioblastoma Multiforme 80 in the EU27 to treat brain cancers with Prostate Cancer 29 NanoTherm therapy Esophageal Cancer 10 Pancreatic Cancer 7 Other Indications ~20 Company Presentation MagForce AG Berlin, Germany O:\Word\2018\SPARED\SPARED CRN 050318

  6. 6 ABLATION OF PROSTATE LESIONS MagForce AG Company Presentation Berlin, Germany

  7. 7 NANOTHERM THERAPY FOR THE ABLATION OF INTERMEDIATE RISK PROSTATE CANCER LESIONS – MAGFORCE USA, INC. Average distance from NanoTherm Ablation 50 ° C iso-contour line to the simulated 43 ° C iso-contour line A Distance measurements A-D B D between the 50 ° C ( red ) ablation contour line and the 43 ° C ( green ) no damage C contour line (H = 10 kA/m). Company Presentation MagForce AG Berlin, Germany O:\Word\2018\SPARED\SPARED CRN 050318

  8. 8 MGF-0115 CLINICAL STUDY – A PIVOTAL, PROSPECTIVE, THREE-STAGE, SINGLE-ARM STUDY OF FOCAL ABLATION OF THE PROSTATE WITH NANOTHERM THERAPY SYSTEM FOR LIMITED-VOLUME, CLINICALLY LOCALIZED, INTERMEDIATE-RISK PROSTATE CANCER Study Stage Description: Stage I: 10 patient study Will demonstrate adequate ablation of tumor tissue Will demonstrate lack of ablation outside target zone Ablative NanoActivation Time: 60 minutes Company Presentation MagForce AG Berlin, Germany O:\Word\2018\SPARED\SPARED CRN 050318

Recommend Documents


nutrition and
Nutrition and Cancer: Fighting Cancer

Nutrition and Cancer: Fighting Cancer With Food Fighting Cancer With Food

antiproton cancer therapy ad 4 ace 4 ace antiproton
Antiproton Cancer Therapy AD- -4/ACE

Antiproton Cancer Therapy AD- -4/ACE 4/ACE Antiproton Cancer Therapy AD

duration of adjuvant therapy for colon cancer
Duration of Adjuvant Therapy for Colon

Duration of Adjuvant Therapy for Colon Cancer Anthony F. Shields, M.D., Ph.D.

tailored adjuvant systemic therapy for breast cancer
TAILORED ADJUVANT SYSTEMIC THERAPY FOR

TAILORED ADJUVANT SYSTEMIC THERAPY FOR BREAST CANCER THERAPY FOR BREAST

chimeric antigen receptor car t cell therapy a cure for
Chimeric Antigen Receptor (CAR) T Cell

Chimeric Antigen Receptor (CAR) T Cell Therapy: A Cure for Cancer? Michael

new zealand s gmo releases
New Zealands GMO releases: Oncolytic

New Zealands GMO releases: Oncolytic viruses for cancer therapy clinical

b hercules
B. hercules The Terminator of Colon

2012 HKUST iGEM Team B. hercules The Terminator of Colon Cancer Background

tailoring cancer therapy in the molecular age
Tailoring Cancer Therapy in the

Tailoring Cancer Therapy in the Molecular Age Nancy E. Davidson, M.D.

novel amp breast amp cancer amp therapy amp should amp we

Novel&Breast&Cancer&Therapy:&

modern radiation therapy opportunities for improved
Modern Radiation Therapy Opportunities

Modern Radiation Therapy Opportunities for Improved Cancer Control Mary

radiofrequency ablation
RADIOFREQUENCY ABLATION ELIZABETH

RADIOFREQUENCY ABLATION ELIZABETH DAVID MD FRCPC VASCULAR AND INTERVENTIONAL

a new amp exciting technology
A New & Exciting Technology

Visualase Therapy: A New & Exciting Technology Jessica Anne Wilden MD

what are my treatment options for af
What Are My Treatment Options for AF?

What Are My Treatment Options for AF? Mikhael El-Chami, MD FACC, FHRS Emory

practical approaches to atrial fibrillation management
Practical Approaches to Atrial

Practical Approaches to Atrial Fibrillation Management Answ ers to Your

venous reflux duplex exam
Venous Reflux Duplex Exam GWENDOLYN

Venous Reflux Duplex Exam GWENDOLYN CARMEL, RVT PHYSIOLOGIST, DEPARTMENT OF

ablation vs amiodarone for treatment of atrial
Ablation vs. Amiodarone for Treatment

Ablation vs. Amiodarone for Treatment of Atrial Fibrillation in Patients with

progress in fielding a zero focus shadowgraph system for
Progress in Fielding a Zero- Focus

Progress in Fielding a Zero- Focus Shadowgraph System for Ablation

adjuvant therapy of thyroid cancer
Adjuvant Therapy of Thyroid Cancer:

Adjuvant Therapy of Thyroid Cancer: rhTSH, RAI, EBRT and Targeted Therapeutics

l ablation dans les ablation dans les l arythmies
L ABLATION DANS LES ABLATION DANS

L ABLATION DANS LES ABLATION DANS LES L ARYTHMIES ARYTHMIES

radiology presentation schedule
Radiology Presentation Schedule

Beth Israel Deaconess Medical Center Radiology Presentation Schedule Sunday,

laser rework capabilities
Laser Rework Capabilities Utilizing

Laser Rework Capabilities Utilizing different laser wavelengths allow for

investor presentation 4q 2018 stereotaxis at a glance
Investor Presentation 4Q 2018

Investor Presentation 4Q 2018 Stereotaxis at a Glance Global Leader in